TPD52 and NFKB1 gene expression levels correlate with G2 chromosomal radiosensitivity in lymphocytes of women with and at risk of hereditary breast cancer

References

• Ahn S H, Sawada H, Ro J Y, Nicolson G L. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clinical and Experimental Metastasis 1997; 15: 151–156
   PubMed Web of Science ®Google Scholar
• Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers W R, Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6: 17–32
   PubMed Web of Science ®Google Scholar
• Antoniou A C, Pharoah P D, McMullan G, Day N E, Ponder B A, Easton D. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genetic Epidemiology 2001; 21: 1–18
   PubMed Web of Science ®Google Scholar
• Asselin-Labat M L, Sutherland K D, Barker H, Thomas R, Shackleton M, Forrest N C, Hartley L, Robb L, Grosveld F G, van der Wees J, Lindeman G J, Visvader J E. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nature Cell Biology 2007; 9: 201–209
   PubMed Web of Science ®Google Scholar
• Balleine R L, Fejzo M S, Sathasivam P, Basset P, Clarke C L, Byrne J A. The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma. Genes Chromosomes Cancer 2000; 29: 48–57
   Google Scholar
• Borresen-Dale A L, Sharma P. Expression profiling of peripheral blood cells for early detection. Breast Cancer Research 2005; 7(Supp2)S8
   Google Scholar
• Boutros R, Byrne J A. D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells. Experimental Cell Research 2005; 310: 152–165
   PubMed Web of Science ®Google Scholar
• Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank products: A simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Letters 2004; 573: 83–92
   PubMed Web of Science ®Google Scholar
• Bryant P E, Gray L, Riches A C, Steel C M, Finnon P, Howe O, Kesterton I, Vral A, Curwen G B, Smart V, Tawn E J, Whitehouse C A. The G2 chromosomal radiosensitivity assay: A technical report. International Journal of Radiation Biology 2002; 78: 863–866
   PubMed Web of Science ®Google Scholar
• Burrill W, Levine E L, Hindocha P, Roberts S A, Scott D. The use of cryopreserved lymphocytes in assessing inter-individual radiosensitivity with the micronucleus assay. International Journal of Radiation Biology 2000; 76: 375–382
   PubMed Web of Science ®Google Scholar
• Byrne J A, Tomasetto C, Garnier J M, Rouyer N, Mattei M G, Bellocq J P, Rio M C, Basset P. A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence. Cancer Research 1995; 55: 2896–2903
   PubMed Web of Science ®Google Scholar
• Cao Q, Chen J, Zhu L, Liu Y, Zhou Z, Sha J, Wang S, Li J. A testis-specific and testis developmentally regulated tumor protein D52 (TPD52)-like protein TPD52L3/hD55 interacts with TPD52 family proteins. Biochemical and Biophysical Research Communications 2006; 344: 798–806
   PubMed Web of Science ®Google Scholar
• Cheung V G, Conlin L K, Weber T M, Arcaro M, Jen K Y, Morley M, Spielman R S. Natural variation in human gene expression assessed in lymphoblastoid cells. Nature Genetics 2003; 33: 422–425
   PubMed Web of Science ®Google Scholar
• Criswell T, Leskov K, Miyamoto S, Luo G, Boothman D A. Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene 2003; 22: 5813–5827
   PubMed Web of Science ®Google Scholar
• Culhane A C, Thioulouse J, Perriere G, Higgins D G. MADE4: An R package for multivariate analysis of gene expression data. Bioinformatics 2005; 21: 2789–2790
   PubMed Web of Science ®Google Scholar
• Ding G R, Honda N, Nakahara T, Tian F, Yoshida M, Hirose H, Miyakoshi J. Radiosensitization by inhibition of IkappaB-alpha phosphorylation in human glioma cells. Radiation Research 2003; 160: 232–237
   PubMed Web of Science ®Google Scholar
• Houlston R S, Peto J. The search for low-penetrance cancer susceptibility alleles. Oncogene 2004; 23: 6471–6476
   PubMed Web of Science ®Google Scholar
• Howe O L, Daly P A, Seymour C, Ormiston W, Nolan C, Mothersill C. Elevated G2 chromosomal radiosensitivity in Irish breast cancer patients: A comparison with other studies. International Journal of Radiation Biology 2005; 81: 373–378
   PubMed Web of Science ®Google Scholar
• Howell A, Sims A H, Ong K R, Harvie M, Evans D G, Clarke R B. Mechanisms of disease: prediction and prevention of breast cancer – cellular and molecular interactions. Nature Clinical Practice Oncology 2005; 2: 635–646
   PubMedGoogle Scholar
• Ihaka R, Gentleman R. R: A language for data analysis and graphics. Journal of Computational and Graphical Statistics 1996; 5: 299–314
   Google Scholar
• Irizarry R A, Hobbs B, Collin F, Beazer-Barclay Y D, Antonellis K J, Scherf U, Speed T P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249–264
   PubMed Web of Science ®Google Scholar
• Jung M, Zhang Y, Lee S, Dritschilo A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. Science 1995; 268: 1619–1621
   PubMed Web of Science ®Google Scholar
• Kontou M, Adelfalk C, Hirsch-Kauffmann M, Schweiger M. Suboptimal action of NF-kappaB in Fanconi anemia cells results from low levels of thioredoxin. Biological Chemistry 2003; 384: 1501–1507
   PubMed Web of Science ®Google Scholar
• Kote-Jarai Z, Matthews L, Osorio A, Shanley S, Giddings I, Moreews F, Locke I, Evans D G, Eccles D, Williams R D, Girolami M, Campbell C, Eeles R. Accurate prediction of BRCA1 and BRCA2 heterozygous genotype using expression profiling after induced DNA damage. Clinical Cancer Research 2006; 12: 3896–3901
   PubMed Web of Science ®Google Scholar
• Kote-Jarai Z, Williams R D, Cattini N, Copeland M, Giddings I, Wooster R, tePoele R H, Workman P, Gusterson B, Peacock J, Gui G, Campbell C, Eeles R. Gene expression profiling after radiation-induced DNA damage is strongly predictive of BRCA1 mutation carrier status. Clinical Cancer Research 2004; 10: 958–963
   PubMed Web of Science ®Google Scholar
• Kouros-Mehr H, Slorach E M, Sternlicht M D, Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 2006; 127: 1041–1055
   PubMed Web of Science ®Google Scholar
• Linard C, Marquette C, Mathieu J, Pennequin A, Clarencon D, Mathe D. Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat: Effect of an NF-kappaB inhibitor. International Journal of Radiation Oncology Biology Physics 2004; 58: 427–434
   PubMed Web of Science ®Google Scholar
• Ma X J, Wang Z, Ryan P D, Isakoff S J, Barmettler A, Fuller A, Muir B, Mohapatra G, Salunga R, Tuggle J T, Tran Y, Tran D, Tassin A, Amon P, Wang W, Wang W, Enright E, Stecker K, Estepa-Sabal E, Smith B, Younger J, Balis U, Michaelson J, Bhan A, Habin K, Baer T M, Brugge J, Haber D A, Erlander M G, Sgroi D C. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004; 5: 607–616
   PubMed Web of Science ®Google Scholar
• Magne N, Toillon R A, Bottero V, Didelot C, Houtte P V, Gerard J P, Peyron J F. NF-kappaB modulation and ionizing radiation: Mechanisms and future directions for cancer treatment. Cancer Letters 2006; 231: 158–168
   PubMed Web of Science ®Google Scholar
• Mehra R, Varambally S, Ding L, Shen R, Sabel M S, Ghosh D, Chinnaiyan A M, Kleer C G. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Research 2005; 65: 11259–11264
   PubMed Web of Science ®Google Scholar
• Mendonca M S, Hardacre M, Datzman N, Comerford K, Chin-Sinex H, Sweeny C. Inhibition of NFKappaB activity by the anti-inflammatory sesquiterpene, parthenolide slows cell growth and increases radiation sensitivity. International Journal of Radiation Oncology-Biology-Physics 2003; 57: S354
   Google Scholar
• Murphy K M, Reiner S L. The lineage decisions of helper T cells. National Review of Immunology 2002; 2: 933–944
   PubMed Web of Science ®Google Scholar
• O'Donovan M R, Freemantle M R, Hull G, Bell D A, Arlett C F, Cole J. Extended-term cultures of human T-lymphocytes: A practical alternative to primary human lymphocytes for use in genotoxicity testing. Mutagenesis 1995; 10: 189–201
   PubMed Web of Science ®Google Scholar
• Pharoah P D, Antoniou A, Bobrow M, Zimmern R L, Easton D F, Ponder B A. Polygenic susceptibility to breast cancer and implications for prevention. Nature Genetics 2002; 31: 33–36
   PubMed Web of Science ®Google Scholar
• Pikarsky E, Ben-Neriah Y. NF-kappaB inhibition: A double-edged sword in cancer?. European Journal of Cancer 2006; 42: 779–784
   PubMed Web of Science ®Google Scholar
• Piret B, Schoonbroodt S, Piette J. The ATM protein is required for sustained activation of NF-kappaB following DNA damage. Oncogene 1999; 18: 2261–2271
   PubMed Web of Science ®Google Scholar
• Roberts S A, Spreadborough A R, Bulman B, Barber J B, Evans D G, Scott D. Heritability of cellular radiosensitivity: A marker of low-penetrance predisposition genes in breast cancer?. American Journal of Human Genetics 1999; 65: 784–794
   PubMed Web of Science ®Google Scholar
• Scott D. Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenetics and Genome Research 2004; 104: 365–370
   PubMed Web of Science ®Google Scholar
• Scott D, Barber J B, Spreadborough A R, Burrill W, Roberts S A. Increased chromosomal radiosensitivity in breast cancer patients: A comparison of two assays. International Journal of Radiation Biology 1999; 75: 1–10
   PubMed Web of Science ®Google Scholar
• Sharma P, Sahni N S, Tibshirani R, Skaane P, Urdal P, Berghagen H, Jensen M, Kristiansen L, Moen C, Zaka A, Arnes J, Sauer T, Akslen L A, Schlichting E, Borresen-Dale A L, Lonneborg A. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Research 2005; 7: R634–644
   PubMed Web of Science ®Google Scholar
• Shen D, Chang H R, Chen Z, He J, Lonsberry V, Elshimali Y, Chia D, Seligson D, Goodglick L, Nelson S F, Gornbein J A. Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochemical and Biophysical Research Communications 2005; 326: 218–227
   PubMed Web of Science ®Google Scholar
• Smart V, Curwen G B, Whitehouse C A, Edwards A, Tawn E J. Chromosomal radiosensitivity: A study of the chromosomal G(2) assay in human blood lymphocytes indicating significant inter-individual variability. Mutation Research 2003; 528: 105–110
   PubMed Web of Science ®Google Scholar
• Soslow R A, Dannenberg A J, Rush D, Woerner B M, Khan K N, Masferrer J, Koki A T. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000; 89: 2637–2645
   PubMed Web of Science ®Google Scholar
• Terzoudi G I, Jung T, Hain J, Vrouvas J, Margaritis K, Donta-Bakoyianni C, Makropoulos V, Angelakis P, Pantelias G E. Increased G2 chromosomal radiosensitivity in cancer patients: The role of cdk1/cyclin-B activity level in the mechanisms involved. International Journal of Radiation Biology 2000; 76: 607–615
   PubMed Web of Science ®Google Scholar
• Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proceedings of the National Academy of Sciences USA 2002; 99: 6567–6572
   PubMed Web of Science ®Google Scholar
• Vral A, Thierens H, Baeyens A, De Ridder L. Chromosomal aberrations and in vitro radiosensitivity: Intra-individual versus inter-individual variability. Toxicology Letters 2004; 149: 345–352
   PubMed Web of Science ®Google Scholar
• Wasserman J, Petrini B, Wolk G, Vedin I, Glas U, Blomgren H, Ekre H P, Strannegard O. Cytokine release from mononuclear cells in patients irradiated for breast cancer. Anticancer Research 1991; 11: 461–464
   PubMed Web of Science ®Google Scholar
• Wilson C L, Miller C J. Simpleaffy: A BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics 2005; 21: 3683–3685
   PubMed Web of Science ®Google Scholar
• Zeeberg B R, Qin H, Narasimhan S, Sunshine M, Cao H, Kane D W, Reimers M, Stephens R M, Bryant D, Burt S K, Elnekave E, Hari D M, Wynn T A, Cunningham-Rundles C, Stewart D M, Nelson D, Weinstein J N. High-Throughput GoMiner, an ‘industrial-strength’ integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 2005; 6: 168
   Google Scholar